US Broker Ratings

Sage Therapeutics, Inc. (SAGE) Stock Analysis: Exploring a 24.44% Potential Upside Amid Strong Revenue Growth

Sage Therapeutics, Inc. (NASDAQ: SAGE) has garnered attention in the biotechnology sector, standing out with a notable potential upside of 24.44% according to analyst consensus. This..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Unpacking a 123.70% Potential Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a significant player in the biotechnology industry, has captured investor interest with an eye-catching potential upside of 123.70% based on..

Abivax SA (ABVX) Investor Outlook: Analyzing a Potential 429% Upside in the Biotech Sector

Abivax SA (ABVX), a prominent player in the biotechnology sector, presents a compelling opportunity for investors with a potential upside of 429.10%, according to analyst ratings...

EyePoint Pharmaceuticals (EYPT): Analyst Consensus Signals a 261% Upside for This Biotech Stock

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) is making waves in the biotechnology sector with a compelling proposition for investors looking for high-growth potential in the healthcare space...

PureTech Health plc (PRTC) Stock Analysis: Exploring a 171.55% Upside Potential in Biotechnology

Investors with an eye on the biotechnology sector may find PureTech Health plc (NASDAQ: PRTC) an intriguing prospect. Based in Boston, Massachusetts, PureTech Health specializes in..

Surmodics, Inc. (SRDX) Stock Analysis: Navigating Challenges with Strategic Innovations in Medical Devices

Surmodics, Inc. (NASDAQ: SRDX) stands at a pivotal junction within the healthcare sector, specifically in the burgeoning field of medical devices. As a company that has..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a 65.73% Potential Upside in the Medical Devices Sector

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a dynamic player in the healthcare sector, specializes in revolutionary medical devices aimed at addressing orthopedic challenges. With a market..

InnovAge Holding Corp. (INNV) Stock Analysis: Navigating a 35.5% Potential Upside in Healthcare

InnovAge Holding Corp. (NASDAQ: INNV) presents an intriguing opportunity for investors looking to tap into the healthcare sector, specifically within the niche of medical care facilities..

Sionna Therapeutics, Inc. (SION) Stock Analysis: A Potential 126.60% Upside in the Biotech Sector

Sionna Therapeutics, Inc. (NASDAQ: SION) is drawing significant attention in the biotechnology sector, particularly for investors looking to capitalize on the burgeoning field of cystic fibrosis..

Kura Oncology, Inc. (KURA) Stock Analysis: Exploring a 289% Potential Upside

Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with a notable potential upside of 289.14%, according to analyst..

Enhabit, Inc. (EHAB) Stock Analysis: Exploring Its 2.81% Upside Potential in the Healthcare Sector

Enhabit, Inc. (NASDAQ: EHAB), a prominent player in the healthcare sector specializing in home health and hospice services, has been drawing the attention of investors amid..

Celcuity Inc. (CELC) Stock Analysis: Biotechnology Innovator with a 126.91% Upside Potential

Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, is gaining significant attention in the healthcare sector due to its innovative approach to cancer treatment. With a..

Capricor Therapeutics, Inc. (CAPR): Investor Outlook Reveals a Compelling 202% Upside Potential

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, is gaining attention in the healthcare sector with its innovative approach to treating diseases with high unmet..

Personalis, Inc. (PSNL) Stock Analysis: Unpacking the 20% Upside Potential

Personalis, Inc. (NASDAQ: PSNL) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $513.17 million, this..

REGENXBIO Inc. (RGNX) Stock Analysis: Biotechnology Innovator with 211% Upside Potential

REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology company, has piqued investor interest with its promising pipeline and remarkable potential upside. With a market capitalization of $511.64..

Septerna, Inc. (SEPN) Stock Analysis: Navigating a 127% Upside Potential in Biotechnology

Septerna, Inc. (NASDAQ: SEPN) stands out in the biotechnology sector with an intriguing investment profile, underscored by a potential upside of 127.35% according to the average..

MeiraGTx Holdings plc (MGTX) Investor Outlook: Potential 317% Upside in the Biotech Sphere

MeiraGTx Holdings plc (NASDAQ: MGTX) offers a compelling opportunity for investors seeking exposure to the burgeoning field of genetic medicine. Specializing in the development of transformative..

KalVista Pharmaceuticals (KALV) Investor Outlook: Exploring a 102% Potential Upside

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a dynamic player in the biotechnology sector, is capturing significant attention from investors, particularly with its potential upside of over 102%...

COMPASS Pathways Plc (CMPS) Investor Outlook: Riding the Wave of a 272% Potential Upside

COMPASS Pathways Plc (NASDAQ: CMPS), a pioneering biotechnology firm focused on mental health, is making waves in the healthcare sector. With a market capitalization of $422.9..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Exploring a 202% Potential Upside in the Biotech Sector

Bicycle Therapeutics plc (NASDAQ: BCYC), a UK-based biotechnology firm, is capturing investor attention with a compelling potential upside of 202.33%. This clinical-stage pharmaceutical company is pioneering..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds